We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-23.97%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.26B
AUM Growth
-$359M
Cap. Flow
+$131M
Cap. Flow %
10.35%
Top 10 Hldgs %
14.56%
Holding
929
New
226
Increased
255
Reduced
141
Closed
293

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
EOG icon
EOG Resources
EOG
+$17.7M
3
LYFT icon
Lyft
LYFT
+$10.9M
4
GE icon
GE Aerospace
GE
+$10.5M
5
AAPL icon
Apple
AAPL
+$10.4M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.8M
2
SMAR
Smartsheet Inc.
SMAR
+$10.2M
3
NOW icon
ServiceNow
NOW
+$9.31M
4
HLT icon
Hilton Worldwide
HLT
+$9.17M
5
PCTY icon
Paylocity
PCTY
+$8.99M

Sector Composition

Rank Sector Weight
1 Healthcare 27.51%
2 Technology 16.97%
3 Consumer Discretionary 13.96%
4 Industrials 10.47%
5 Financials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RACE icon
1
Ferrari
RACE
$63.3B
$33.5M 2.65%
214,718
-18,199
-8% -$2.93M
ABBV icon
2
AbbVie
ABBV
$458B
$31.8M 2.52%
417,300
+319,900
+328% +$27.2M
HUM icon
3
Humana
HUM
$46.7B
$24.8M 1.96%
78,818
-13,983
-15% -$4.72M
EOG icon
4
EOG Resources
EOG
$78B
$18.3M 1.45%
510,424
+272,509
+115% +$17.7M
CGNX icon
5
Cognex
CGNX
$10.3B
$18.3M 1.45%
434,203
+13,601
+3% +$681K
REGN icon
6
Regeneron Pharmaceuticals
REGN
$68.8B
$14.8M 1.18%
30,400
+1,399
+5% +$577K
DXCM icon
7
DexCom
DXCM
$27.6B
$11.1M 0.88%
164,400
-22,800
-12% -$1.42M
BIIB icon
8
Biogen
BIIB
$29.9B
$11M 0.87%
34,622
+2,501
+8% +$759K
CME icon
9
CME Group
CME
$92.2B
$10.4M 0.82%
60,000
-4
-0% -$796
DINO icon
10
HF Sinclair
DINO
$15.9B
$9.96M 0.79%
406,321
+254,321
+167% +$9.5M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$9.8M 0.78%
109,159
+25,028
+30% +$2.46M
GILD icon
12
Gilead Sciences
GILD
$161B
$9.67M 0.77%
+129,300
New +$8.93M
VTRS icon
13
Viatris
VTRS
$20.1B
$9.59M 0.76%
643,406
+83,825
+15% +$1.61M
A icon
14
Agilent Technologies
A
$39.1B
$9.49M 0.75%
132,571
+63
+0% +$5.06K
RMD icon
15
ResMed
RMD
$28.3B
$9.43M 0.75%
64,018
+8
+0% +$1.27K
MNST icon
16
Monster Beverage
MNST
$91.4B
$9.33M 0.74%
331,800
– –
PODD icon
17
Insulet
PODD
$11.3B
$9.17M 0.73%
55,337
+32
+0.1% +$5.85K
AXON
18
Axon Enterprise
AXON
$40.5B
$9.04M 0.72%
+127,700
New +$9.56M
SIVB
19
DELISTED
SVB Financial Group
SIVB
$9.04M 0.72%
59,810
+20,875
+54% +$4.59M
PFE icon
20
Pfizer
PFE
$140B
$9.03M 0.71%
291,458
-18,102
-6% -$617K
AAPL icon
21
Apple
AAPL
$4.89T
$9.01M 0.71%
+141,776
New +$10.4M
IPHI
22
DELISTED
INPHI CORPORATION
IPHI
$8.94M 0.71%
112,900
+29,281
+35% +$2.28M
ROP icon
23
Roper Technologies
ROP
$36.3B
$8.92M 0.71%
28,600
-1,100
-4% -$390K
PEN icon
24
Penumbra
PEN
$12.5B
$8.86M 0.7%
54,900
+100
+0.2% +$16.8K
V icon
25
Visa
V
$677B
$8.72M 0.69%
54,113
-5
-0% -$942
1
2 3 4 5

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q1 2020 Portfolio in Review

As of Q1 2020, PDT Partners held 929 positions worth $1.26B, down 22% from $1.62B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

PDT Partners deployed $131M of net new capital in Q1 2020, opening 226 new positions and adding to 255 existing holdings. Its largest new stake was GE Aerospace: 196,102 shares worth $7.76M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Paylocity, an estimated $8.99M trimmed.

  • PDT Partners's largest Q1 2020 buy was GE Aerospace: 196,102 shares worth $7.76M.
  • PDT Partners added most to AbbVie in Q1 2020, an estimated $27.2M increase.
  • PDT Partners's biggest Q1 2020 reduction was Paylocity, cutting an estimated $8.99M.
  • PDT Partners fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $10.8M.
  • PDT Partners's ten largest holdings make up 15% of its $1.26B portfolio in Q1 2020.
  • PDT Partners opened 226 new positions and closed 293 in Q1 2020.
  • PDT Partners's portfolio value fell 22% quarter-over-quarter to $1.26B.

Based on PDT Partners's 13F filing for Q1 2020, filed 15 May 2020.